Ex­clu­sive: Pfiz­er to in­vest $25M in­to tiny UK biotech with epi­ge­net­ics ap­proach to can­cer

Cam­bridge, UK-based start­up Cell­Cen­tric is re­ceiv­ing $25 mil­lion to fin­ish on­go­ing clin­i­cal stud­ies and get some ex­tra run­way in the form of a cash in­fu­sion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER